ADVFN - ニュース

US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/28	05 : 42	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:OLOXF	DB Crude Oil Long ETN due June 1 2038 (PK)
2024/09/28	05 : 42	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:GORV	Lazydays Holdings Inc
2024/09/28	05 : 42	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PINC	Premier Inc
2024/09/28	05 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRM	Salesforce Inc
2024/09/28	05 : 42	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJB	Alerian Mlp Index ETNs due January 28 2044
2024/09/28	05 : 42	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/09/28	05 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:KSS	Kohls Corporation
2024/09/28	05 : 42	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BDRX	Biodexa Pharmaceuticals PLC
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BDRX	Biodexa Pharmaceuticals PLC
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:GSCE	Goldman Sachs Group Inc (PK)
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BDRX	Biodexa Pharmaceuticals PLC
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BDRX	Biodexa Pharmaceuticals PLC
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BDRX	Biodexa Pharmaceuticals PLC
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BDRX	Biodexa Pharmaceuticals PLC
2024/09/28	05 : 41	Alliance News	US still thinks "path to diplomacy" open in Middle East - Blinken
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BDRX	Biodexa Pharmaceuticals PLC
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:GSCE	Goldman Sachs Group Inc (PK)
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:WTIU	Microsectors Energy 3x Leveraged ETN
2024/09/28	05 : 41	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/09/28	05 : 41	Business Wire	BNY Mellon Municipal Bond Closed-End Funds Declare Distributions	NYSE:LEO	BNY Mellon Strategic Municipals Inc
2024/09/28	05 : 41	Business Wire	BNY Mellon Municipal Bond Closed-End Funds Declare Distributions	NYSE:DSM	BNY Mellon Strategic Municipal Bond Fund Inc
2024/09/28	05 : 41	Business Wire	BNY Mellon Municipal Bond Closed-End Funds Declare Distributions	AMEX:DMF	BNY Mellon Municipal Income Inc
2024/09/28	05 : 41	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:BACRP	Bank of America Corp (PK)
2024/09/28	05 : 40	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:GSCE	Goldman Sachs Group Inc (PK)
2024/09/28	05 : 40	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:MSTLW	Morgan Stanley (PK)
2024/09/28	05 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CULP	Culp Inc
2024/09/28	05 : 40	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:GSCE	Goldman Sachs Group Inc (PK)
2024/09/28	05 : 40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MVIS	Microvision Inc
2024/09/28	05 : 40	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NASDAQ:IBIT	iShares Bitcoin Trust ETF

1 2 3 4 5 6 7 8 9 10 次へ >>

Hsbc France 1.35% jul2027

Invesco Investment Grade...

Swiss Prime Site (PK)

XinFin Development Contract

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約